AngioDynamics Inc Overview
Industry: Medical Instruments & Supplies
Sector: Healthcare
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationall Read MoreMavefund brings filings, fundamentals, valuation, price history and news for AngioDynamics Inc into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Net sales was $86.6 (reported); EPS was $0.29 (reported).
What changed
- Net sales reported to $86.6; EPS reported to $0.29.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands
Headline from Yahoo Finance: AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands.
AngioDynamics beats estimates on revenue and guidance strength
Headline from Investing.com UK: AngioDynamics beats estimates on revenue and guidance strength.
AngioDynamics beats estimates on revenue and guidance strength By Investing.com
Headline from Investing.com Canada: AngioDynamics beats estimates on revenue and guidance strength By Investing.com.
AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript
Headline from The Motley Fool: AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript.
Earnings call transcript: AngioDynamics beats Q4 2026 estimates, shares rise By Investing.com
Headline from Investing.com Nigeria: Earnings call transcript: AngioDynamics beats Q4 2026 estimates, shares rise By Investing.com.
AngioDynamics earnings beat by $0.02, revenue topped estimates
Headline from Investing.com: AngioDynamics earnings beat by $0.02, revenue topped estimates.
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.